Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.
about
Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Arg-Leu-Tyr-Glu tetrapeptide i ...... ia VEGF receptor-2 antagonism.
@en
Arg-Leu-Tyr-Glu tetrapeptide i ...... ia VEGF receptor-2 antagonism.
@nl
type
label
Arg-Leu-Tyr-Glu tetrapeptide i ...... ia VEGF receptor-2 antagonism.
@en
Arg-Leu-Tyr-Glu tetrapeptide i ...... ia VEGF receptor-2 antagonism.
@nl
prefLabel
Arg-Leu-Tyr-Glu tetrapeptide i ...... ia VEGF receptor-2 antagonism.
@en
Arg-Leu-Tyr-Glu tetrapeptide i ...... ia VEGF receptor-2 antagonism.
@nl
P2093
P2860
P356
P1433
P1476
Arg-Leu-Tyr-Glu tetrapeptide i ...... ia VEGF receptor-2 antagonism.
@en
P2093
Dong-Keon Lee
Dooil Jeoung
Hansoo Lee
Ji Chang You
Ji-Hee Kim
Joohwan Kim
Kwon-Soo Ha
Moo-Ho Won
Sanghwa Han
Taesam Kim
P2860
P304
11763-11777
P356
10.18632/ONCOTARGET.14343
P407
P577
2016-12-28T00:00:00Z